Wells Fargo & Company Aziyo Biologics, Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	N/A	2 Added 1.82%	112 $0
Q4 2023 Feb 09, 2024	BUY	$1.14 - $1.45 $63 - $81	56 Added 103.7%	110 $0
Q3 2023 Nov 13, 2023	SELL	$1.13 - $2.52 $5 - $12	-5 Reduced 8.47%	54 $0
Q2 2023 Aug 15, 2023	BUY	$1.41 - $2.79 $4 - $8	3 Added 5.36%	59 $0
Q1 2023 May 12, 2023	BUY	$1.19 - $4.96 $20 - $84	17 Added 43.59%	56 $0
Q4 2022 Feb 13, 2023	BUY	$3.48 - $8.94 $3 - $8	1 Added 2.63%	39 $0
Q3 2022 Nov 14, 2022	BUY	$5.72 - $7.76 $45 - $62	8 Added 26.67%	38 $0
Q2 2022 Aug 12, 2022	BUY	$5.75 - $7.41 $17 - $22	3 Added 11.11%	30 $0
Q3 2021 Nov 15, 2021	BUY	$6.75 - $9.52 $94 - $133	14 Added 107.69%	27 $0
Q2 2021 Aug 16, 2021	SELL	$9.51 - $13.97 $7,921 - $11,637	-833 Reduced 98.46%	13 $0
Q1 2021 May 13, 2021	SELL	$13.08 - $16.41 $6,696 - $8,401	-512 Reduced 37.7%	846 $12,000
Q4 2020 Feb 09, 2021	BUY	$10.77 - $14.82 $14,625 - $20,125	1,358 New	1,358 $19,000

9.06M

893K

Ticker AZYO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 9,308,720
Market Cap $13.5M
Description
Aziyo Biologics, Inc., a regenerative medicine company, focuses on the development of regenerative medical products to address the implantable electronic device/cardiovascular, orthopedic/spinal repair, and soft tissue reconstruction markets. It offers CanGaroo that combines the envelope with antibiotics and is designed to reduce the risk of inf...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.